1. Impact of sigmoid septum on periprocedural outcomes following transcatheter aortic valve implantation using current-generation valves
- Author
-
Yasuharu Matsunaga-Lee, Masamichi Yano, Hitoshi Nakamura, Masaki Tsuda, Koji Yasumoto, Naotaka Okamoto, Jun Tanouchi, Yasuyuki Egami, Yutaka Matsuhiro, and Masami Nishino
- Subjects
medicine.medical_specialty ,Current generation ,Transcatheter aortic ,Hemodynamics ,Computed tomography ,Pacemaker implantation ,Transcatheter Aortic Valve Replacement ,Predictive Value of Tests ,Internal medicine ,Humans ,Medicine ,Radiology, Nuclear Medicine and imaging ,Heart valve ,Cardiac skeleton ,Heart Valve Prosthesis Implantation ,Body surface area ,medicine.diagnostic_test ,business.industry ,Aortic Valve Stenosis ,Treatment Outcome ,medicine.anatomical_structure ,Aortic Valve ,Heart Valve Prosthesis ,Cardiology ,Female ,Cardiology and Cardiovascular Medicine ,business - Abstract
The role of sigmoid septum (SS) observed using preprocedural transthoracic echocardiography (TTE) in patients undergoing transcatheter aortic valve implantation (TAVI) remains unknown. This study aimed to compare clinical outcomes of TAVI using the current-generation transcatheter heart valves in patients with and without SS. We divided 140 consecutive patients, excluding four patients who underwent pacemaker implantation before TAVI, into two groups (those with and without SS) and compared the periprocedural outcomes, including new pacemaker implantation, within 30 days post-TAVI. Thirty-five patients (25%; 32 female patients) had SS before TAVI. The body surface area and aortic annulus area measured using computed tomography were significantly smaller in patients with SS than in those without SS (1.40 m2 vs. 1.48 m2, P = 0.03; and 372 mm2 vs. 409 mm2, P
- Published
- 2021